NeuroCOVID-19

Research into long-haul COVID-19, based in Toronto, Canada.

Our Scientific mission

The NeuroCOVID-19 research project is investigating long-haul COVID-19 symptoms affecting members of our communities using state-of-the-art neuroimaging techniques.

Many individuals who have recovered from COVID-19 continue to experience persistent \"long-haul\" symptoms, such as fatigue, brain fog, and cognitive or psychiatric challenges. These symptoms suggest that COVID-19 may have lasting effects on brain function. Studies estimate that hundreds of thousands of Canadians, and millions globally, could face long-term symptoms that affect daily activities and quality of life.

The NeuroCOVID-19 project involves comprehensive assessments of sensation, cognition, and emotion; self-reported symptoms; electroencephalography (EEG) to measure brain activity; and magnetic resonance imaging (MRI) to visualize brain structures. Through this work, we aim to better understand how COVID-19 affects the brain and to use this knowledge to develop patient-specific treatments, ultimately improving the health and well-being of many Canadians.

View this project on the Sunnybrook page HERE.